Brief: Piramal Pharma Says US FDA Inspection At Turbhe Facility
18/02/2025 11:33
Feb 18 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* US FDA INSPECTION AT PIRAMAL PHARMA'S FACILITY LOCATED AT
TURBHE
* ON CONCLUSION OF INSPECTION, A FORM-483 WAS ISSUED WITH 6
OBSERVATIONS
Source text: ID:nBSE410CGn
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington